TGA
We’ve updated the Listed Medicine Compliance Reports database with the results of compliance reviews covering 13 listed medicines, including:
- medicines reviewed to check whether they meet stability requirements
- medicines reviewed to check evidence to support health claims about exercise performance
- medicines with non-permitted health claims about:
- nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN),
- fertility, preconception health and use by postpartum and breastfeeding women,
- arthritis, osteoarthritis, irritable bowel syndrome, stomach ulcers, balancing cholesterol levels, autoimmune skin conditions, psoriasis, eczema, and rosacea.
Following the reviews, 8 of these medicines have been cancelled from the Australian Register of Therapeutic Goods (ARTG) and are no longer permitted to be supplied.
/Public Release. View in full here.
